Everett Vokes to Aminopyridines
This is a "connection" page, showing publications Everett Vokes has written about Aminopyridines.
Connection Strength
0.151
-
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer. Head Neck. 2019 11; 41(11):3842-3849.
Score: 0.151